Today's NYSE & NASDAQ Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
BKR Baker Hughes	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Laetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$62.75 +1.8%	$70.00
CELH Celsius	Downgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristian Rios Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.77 -18.5%	$26.00	Outperform ➝ Market Perform
CRWV CoreWeave	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$85.33 -5.1%		Buy
CVRX CVRx	Downgraded by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.94 +6.5%	$4.00	Overweight ➝ Neutral
DBX Dropbox	Upgraded by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.54 -1.3%		Market Perform
DNA Ginkgo Bioworks	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.57 -8.6%		Buy ➝ Hold
DV DoubleVerify	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.75 -2.0%		Outperform ➝ Market Perform
DV DoubleVerify	Downgraded by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.75 -2.0%	$13.60	Outperform ➝ Sector Perform
DV DoubleVerify	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.75 -2.0%		Outperform ➝ Market Perform
DV DoubleVerify	Target Set by	Nomura Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.75 -2.0%	$13.60
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
DV DoubleVerify	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Youssef Squali Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.75 -2.0%	$13.60
EXFY Expensify	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.98 -2.0%		Market Outperform ➝ Outperform
FUN Six Flags Entertainment	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.72 -16.1%	$10.00
NET Cloudflare	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$283.33 -3.3%	$355.00	Overweight
ONTO Onto Innovation	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$270.41 -2.0%	$400.00	Buy
PAYO Payoneer Global	Downgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.11 -0.1%		Buy ➝ Hold
PUBM PubMatic	Upgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.48 -0.2%	$22.00	Market Perform ➝ Outperform
PWR Quanta Services	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$666.67 -2.4%	$807.00	Overweight
RGNX REGENXBIO	Downgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gena Wang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.28 +7.4%		Overweight ➝ Positive
RLAY Relay Therapeutics	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Canino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.75 +0.3%		Buy
RXO RXO	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ariel Rosa Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.20 -3.8%		Market Perform ➝ Outperform
STRO Sutro Biopharma	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Prendergast Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.15 -3.8%	$48.00
TSEM Tower Semiconductor	Upgraded by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$224.70 +6.4%		Buy
TTD Trade Desk	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Youssef Squali Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.67 -6.8%	$16.00
TTD Trade Desk	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.67 -6.8%		Market Perform ➝ Underperform
TTD Trade Desk	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Kesavabhotla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.67 -6.8%	$9.00
TTD Trade Desk	Target Set by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.67 -6.8%	$12.00
TTD Trade Desk	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Morris Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.67 -6.8%		Buy ➝ Neutral
UWMC UWM	Target Set by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Douglas Harter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.20 -35.1%	$2.00

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 06:58 AM ET.

Frequently Asked Questions

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NYSE and NASDAQ Stock Price Targets and Analyst Ratings

Frequently Asked Questions

What are analyst ratings?

Should you trust analyst ratings?

What does an analyst rating tell you about a stock?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools